These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


182 related items for PubMed ID: 14716862

  • 1. [Experimental study of controlled release microencapsulated Salmonella typhi capsular polysaccharide vaccines immunized mice].
    Yang C, Yan R, Zeng W, Zhang Y, Jia W, Liu J, Zhou S, Li X, Deng X.
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Dec; 20(4):626-9. PubMed ID: 14716862
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide.
    Tacket CO, Pasetti MF, Sztein MB, Livio S, Levine MM.
    J Infect Dis; 2004 Aug 01; 190(3):565-70. PubMed ID: 15243933
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Nasal immunization of mice with AFCo1 or AFPL1 plus capsular polysaccharide Vi from Salmonella typhi induces cellular response and memory B and T cell responses.
    Romeu B, Lastre M, Reyes L, González E, Borrero Y, Lescaille D, Pérez R, Nuñez D, Pérez O.
    Vaccine; 2014 Dec 05; 32(51):6971-6978. PubMed ID: 25454865
    [Abstract] [Full Text] [Related]

  • 6. Revaccination with locally-produced vi typhoid polysaccharide vaccine among chinese school-aged children: safety and immunogenicity findings.
    Zhou WZ, Koo HW, Wang XY, Zhang J, Park JK, Zhu F, Deen J, Acosta CJ, Chen Y, Wang H, Galindo CM, Ochiai L, Park T, von Seidlein L, Xu ZY, Clemens JD.
    Pediatr Infect Dis J; 2007 Nov 05; 26(11):1001-5. PubMed ID: 17984806
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of phoP and rpoS mutants of Salmonella enterica serovar Typhi as attenuated typhoid vaccine candidates: virulence and protective immune responses in intranasally immunized mice.
    Lee HY, Cho SA, Lee IS, Park JH, Seok SH, Baek MW, Kim DJ, Lee SH, Hur SJ, Ban SJ, Lee YK, Han YK, Cho YK, Park JH.
    FEMS Immunol Med Microbiol; 2007 Nov 05; 51(2):310-8. PubMed ID: 17725620
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Terminal Deoxynucleotidyl Transferase Is Not Required for Antibody Response to Polysaccharide Vaccines against Streptococcus pneumoniae and Salmonella enterica Serovar Typhi.
    Belde V, Cravens MP, Gulandijany D, Walker JA, Palomo-Caturla I, Alugupalli AS, Sandilya VK, Mahmoud T, Bäumler AJ, Kearney JF, Alugupalli KR.
    Infect Immun; 2018 Sep 05; 86(9):. PubMed ID: 29967094
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Intraperitoneal immunization of recombinant HSP70 (DnaK) of Salmonella Typhi induces a predominant Th2 response and protective immunity in mice against lethal Salmonella infection.
    Paliwal PK, Bansal A, Sagi SS, Sairam M.
    Vaccine; 2011 Sep 02; 29(38):6532-9. PubMed ID: 21767594
    [Abstract] [Full Text] [Related]

  • 12. [Immunization with targeted fusion anticaries DNA vaccine via intramuscular route:experiment with murine].
    Yu F, Fan MW, Xu QA, Jia R, Guo JH, Bian Z, Chen Z, Peng B, Fan B.
    Zhonghua Yi Xue Za Zhi; 2004 May 02; 84(9):754-9. PubMed ID: 15200917
    [Abstract] [Full Text] [Related]

  • 13. Protective efficacy and immunogenicity of Vi-porin conjugate against Salmonella typhi.
    Singh M, Ganguly NK, Kumar L, Vohra H.
    Microbiol Immunol; 1999 May 02; 43(6):535-42. PubMed ID: 10480549
    [Abstract] [Full Text] [Related]

  • 14. [Monoclonal antibodies against the lipopolysaccharide of Salmonella typhi 9,12,VI:d. Analysis of passive protection in a mouse model of typhoid fever].
    Paniagua J, Isibasi A, Pelayo R, Ortiz V, Muy M, González C, García JA, Islas S.
    Arch Invest Med (Mex); 1989 May 02; 20(4):315-20. PubMed ID: 2488771
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Serological response following re-vaccination with Salmonella typhi Vi-capsular polysaccharide vaccines in healthy adult travellers.
    Roggelin L, Vinnemeier CD, Fischer-Herr J, Johnson-Weaver BT, Rolling T, Burchard GD, Staats HF, Cramer JP.
    Vaccine; 2015 Aug 07; 33(33):4141-5. PubMed ID: 26144902
    [Abstract] [Full Text] [Related]

  • 17. The novel oral typhoid vaccine M01ZH09 is well tolerated and highly immunogenic in 2 vaccine presentations.
    Kirkpatrick BD, Tenney KM, Larsson CJ, O'Neill JP, Ventrone C, Bentley M, Upton A, Hindle Z, Fidler C, Kutzko D, Holdridge R, Lapointe C, Hamlet S, Chatfield SN.
    J Infect Dis; 2005 Aug 01; 192(3):360-6. PubMed ID: 15995948
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.